NASDAQ: BTMD
Biote Corp Stock Ownership - Who owns Biote?

Insider buying vs selling

Have Biote Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Guines LLC10% Owner2025-05-0711,677$3.35
$39.11kBuy
Guines LLC10% Owner2025-05-06436,037$3.26
$1.42MBuy
Guines LLC10% Owner2025-04-301,933$3.30
$6.37kBuy
Guines LLC10% Owner2025-04-218,801$3.27
$28.78kBuy
Guines LLC10% Owner2025-04-176,874$3.29
$22.62kBuy
Guines LLC10% Owner2025-04-161,000$3.29
$3.29kBuy
Guines LLC10% Owner2025-04-0913,532$3.21
$43.40kBuy
Guines LLC10% Owner2025-04-0834,907$3.21
$111.98kBuy
Guines LLC10% Owner2025-04-0743,378$3.15
$136.68kBuy
Guines LLC10% Owner2025-04-0423,741$3.24
$76.94kBuy

1 of 3

BTMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTMD insiders and whales buy or sell their stock.

BTMD Shareholders

What type of owners hold Biote Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gary Steven Donovitz49.26%22,494,946$57.59MInsider
Guines LLC19.24%8,787,048$22.49MInsider
325 Capital LLC9.96%4,548,127$11.64MInstitution
325 Capital LLC8.25%3,766,666$9.64MInsider
Andrew R. Heyer6.76%3,089,049$7.91MInsider
Roystone Capital Management LP6.73%3,070,938$7.86MInsider
Bandera Partners LLC5.00%2,283,791$5.85MInstitution
Blackrock Inc3.82%1,742,776$4.46MInstitution
Vanguard Group Inc3.12%1,426,951$3.65MInstitution
Steven J. Heyer1.60%729,856$1.87MInsider

1 of 3

BTMD vs Medical Care Facility Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTMD26.71%73.29%Net Buying
JYNT51.71%48.29%Net BuyingNet Buying
DCGO50.07%24.52%Net Selling
AIRS46.55%53.45%Net Buying
NAKA24.72%5.85%Net Buying

Biote Stock Ownership FAQ

Who owns Biote?

Biote (NASDAQ: BTMD) is owned by 34.07% institutional shareholders, 93.51% Biote insiders, and 0.00% retail investors. Gary Steven Donovitz is the largest individual Biote shareholder, owning 22.49M shares representing 49.26% of the company. Gary Steven Donovitz's Biote shares are currently valued at $61.19M.

If you're new to stock investing, here's how to buy Biote stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.